ST14 and cancer: The enzyme matriptase, a membrane-anchored protease that is overexpressed in cancer, is inhibited by engineered MCoTI-based inhibitor by substituting P4 Val for Arg, P1’ Ile to Ala replacement resulted in higher affinity for matriptase and decreased the inhibitors off-target activity against trypsin (Quimbar et al. 2013).